Do any of these studies of "medical reversals" attempt to estimate how often reversals should be made ideally?
Do any of these studies of "medical reversals" attempt to estimate how often reversals should be made ideally?
Indeed, from the second paragraph (emphasis mine):
> Medical reversals are a subset of low-value medical practices and are defined as practices that have been found, through randomized controlled trials, to be no better than a prior or lesser standard of care (Prasad et al., 2013; Prasad et al., 2011).
That is, the authors assert that something is low value if it is later proven to not work.
Why give any treatment that hasn't been through a randomised trial? (Unless, of course, you are giving it as part of a trial)
Shouldn't the focus be on applying treatments backed by robust evidence in the first place, rather than on medical reversals? Of course the two are connected, but the wording seems odd. Medical reversals seem to be a symptom of the problem, not the root cause.
Of course, I might be misunderstanding the terminology.
edit: I've read the abstract and it seems I am indeed misunderstanding the definition, but for the life of me I cannot understand what "medical reversal" means in layman words.
I was confused because "reversal" sounds to me as the act of ceasing to do something, i.e. "reverting" the treatment (if you're a programmer: I thought of "reversal" as in "reverting a mistaken commit using git"). I now see it's a technical term which means the opposite!
Now it all makes sense.
I think an important difference is that current clinical practice is not necessarily thought to be "unproven/inconclusive." Rather, I think people think it has a solid foundation, but better investigation reveals that not to be true.
Medical reversal occurs when a new clinical trial — superior to predecessors by virtue of better controls, design, size, or endpoints — contradicts current clinical practice. In recent years, we have witnessed several instances of medical reversal. Famous examples include the class 1C anti-arrhythmics post-myocardial infarction (contradicted by the CAST trial) or routine stenting for stable coronary disease (contradicted by the COURAGE trial).
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3238324/
The article I link to has one author common with the paper originally posted, way above. Shame that this author seems to have lost the skill of ensuring that terms are propery defined.
In days past a lot of medicine was based on what seems to work or what ought to work. Unless the effect is really obviously disastrous it's easy to believe an intervention is helping even if it's not. Medical research was of course done but doctors mostly went with their gut or whatever article they'd recently read in a journal and liked the sound of.
It's only since the late 80's and through the 90's that Evidence Based Medicine really started to get going. Since then doctors have (sometimes slowly) come round to the idea. However all this research takes time. What do you do about those interventions that haven't been tested yet?
You could stop doing anything that hasn't been thoroughly researched, but that risks letting people die or suffering unnecessarily.
The classic tongue-in-cheek example is parachutes:
> Objectives: To determine whether parachutes are effective in preventing major trauma related to gravitational challenge.
> Design: Systematic review of randomised controlled trials.
> Main outcome measure: Death or major trauma, defined as an injury severity score > 15.
> Results: We were unable to identify any randomised controlled trials of parachute intervention.
> Conclusions: As with many interventions intended to prevent ill health, the effectiveness of parachutes has not been subjected to rigorous evaluation by using randomised controlled trials. Advocates of evidence based medicine have criticised the adoption of interventions evaluated by using only observational data. We think that everyone might benefit if the most radical protagonists of evidence based medicine organised and participated in a double blind, randomised, placebo controlled, crossover trial of the parachute.
It turns out that study design can also be a problem, even with 'gold standard' designs like the RCT...